https://www.selleckchem.com/
Psoriatic arthritis (PsA), an inflammatory arthritis that develops in individuals with psoriasis, is associated with reduced quality of life. Identifying biomarkers associated with development of PsA as well as with PsA disease activity may help management of psoriatic disease. To use metabolomic fingerprinting to determine potential candidate markers of disease conversion (psoriasis to PsA) and/or PsA activity. A novel sample preparation protocol based on solid-phase microextraction (SPME) was used to prepare serum samples obtained from (1) individuals wit
Like
Comment
Share
